Adverse effect of local anesthetics, subsequent encounter

This code indicates a patient is experiencing an undesirable or harmful reaction to a local anesthetic, such as lidocaine or bupivacaine, during a subsequent phase of treatment. This adverse effect is not due to an overdose or poisoning, but rather an unexpected physiological response to a properly administered therapeutic dose. The "subsequent encounter" signifies that the patient is receiving follow-up care for the adverse effect after the initial treatment.

Use this code when a patient presents for ongoing management or evaluation of an adverse reaction to a local anesthetic that was initially treated or identified in a previous encounter. Examples include a patient returning to the clinic for persistent localized rash, nerve paresthesia, or systemic symptoms (e.g., dizziness, palpitations) that developed after receiving a local anesthetic for a procedure, and the current visit is for monitoring or further intervention.

• Always sequence this code after the primary diagnosis for which the patient is being treated, unless the adverse effect is the primary reason for the encounter.
• Ensure documentation clearly distinguishes an adverse effect from poisoning, underdosing, or allergic reaction, as these have different code categories.
• Verify the encounter type is indeed "subsequent" (D) and not "initial" (A) or "sequela" (S) based on the patient's treatment progression for the adverse effect.